NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Crisil Predicts 200 Basis Point Hit to Corporate Profitability Due to West Asia Conflict

Prolonged supply-chain disruptions due to the ongoing conflict in West Asia could shave off corporate operating profitability by 200 basis points (bps) in the current fiscal year, according to a stress test conducted by Crisil Ratings. However, the domestic rating agency expects India Inc to remain resilient on the back of strong balance sheets.

Crisil's stress test revealed that the protracted conflict has prompted domestic companies to realign their supply chains, navigate pricing issues, manage higher fuel and freight costs, and contend with a depreciating rupee. The conflict and disruptions, now in their third month, are expected to exacerbate inflation and amplify demand disruption if prolonged further.

Crisil conducted a stress test of 34 sectors, which account for 65% of its rated corporate debt, assuming supply-chain disruptions could last for nine months this fiscal, compared with six months in its base case. The agency has also assumed crude oil prices averaging USD 110 per barrel for this fiscal year, versus a base case assumption of USD 95.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

The stress test assessed the impact on sectoral revenue, operating profitability, and the resilience provided by balance-sheet strength to determine the impact on credit quality. According to the results, the prolonged supply-chain disruptions could shave off corporate operating profitability by 200 basis points (bps) this fiscal from the pre-conflict expectation of 12%.

However, Crisil analysis showed that India Inc will remain resilient on the back of strong balance sheets, steady domestic demand, and government-led capital expenditure, enabling it to navigate profitability pressures stemming from the lingering geopolitical uncertainties.

SectorPre-Conflict ExpectationProjected Impact
Corporate Sector12%10.8%
Pharmaceuticals15%12.5%
Textiles12%10%
Readymade Garments15%12%
Shrimp Processors15%12.5%
Electronics15%12%

Export-linked sectors such as pharmaceuticals, textiles, readymade garments, shrimp processors, and electronics manufacturers may benefit from the rupee's depreciation, according to Crisil. Managing costs and profitability will be a bigger challenge than achieving topline growth for companies, said Crisil Ratings Managing Director Subodh Rai.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Crisil foresees the credit quality of only eight sectors, accounting for 10% of its rated corporate debt, being materially impacted.

Investor Takeaway

Investors should be cautious of potential supply-chain disruptions and their impact on corporate profitability.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.